Tag: thrombectomy

First patient enrolled in TIGER pivotal clinical study

The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...

RAPID CTA gets FDA clearance

iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...

Vesalio reports positive results in early NeVa human thrombectomy procedures and...

Vesalio has announced that it has completed European enrolment of the first twenty-five human cases in a post-market registry of the proprietary NeVa neurothrombectomy...

Tenecteplase reduces the need for thrombectomy compared to alteplase

Results from the Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK) study show that the use of tenecteplase (0.25mg/kg) led to...

Long stent retrievers associated with increased rates of first-pass reperfusion

Longer stent retrievers were found independently associated with higher rates of first-pass reperfusion and should be favoured over their shorter counterparts in light of...

A new approach to mechanical thrombectomy: The SAVE technique

As mechanical thrombectomy continues to be established as the standard of care for the treatment of patients with large vessel occlusion stroke, investigators strive...

Perflow Medical closes US$12 million in financing to treat complex neurovascular...

Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, today announced that the company has closed $12 million in...

FDA expands treatment window for use of clot retrieval devices in...

The US Food and Drug Administration has cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24...

COMPASS study finds ADAPT non-inferior to stent retriever for first-line mechanical...

The COMPASS study has found that the use of ADAPT as first-line mechanical thrombectomy therapy for acute ischaemic stroke results in non-inferior functional outcomes...

New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...

The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...

To By-Pass or Not To By-Pass

In this educational supplement we focus on ischaemic stroke. We look at the results of the ASTER trial and experts weigh in on the...

The Joint Commission, American Heart Association/American Stroke Association announce new thrombectomy...

The Joint Commission, in collaboration with the American Heart Association/American Stroke Association, the world’s leading voluntary health organisation devoted to fighting cardiovascular disease and...

Two trials validate use of image-based selection for late window stroke...

With the results of the DAWN trial now published in the New England Journal of Medicine and the late time window data from the...

John Muir Health awarded Comprehensive Stroke Certification Accreditation

John Muir Health’s Walnut Creek Medical Center, Walnut Creek, USA, has been awarded Comprehensive Stroke Certification Accreditation by The Joint Commission, which accredits and...

First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry

  The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...

DEFUSE 3 terminated early with high likelihood of benefit in the...

Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...

Significant reduction in hospital workflow times with direct transfer to angiosuite

A new study from Barcelona has shown that in a subgroup of patients, direct transfer and triage in the angiosuite seems feasible, safe, and achieves significant...

Treatment at high-volume centres more beneficial for stroke patients despite transfer...

In a study published in the journal Stroke, Lorenzo Rinaldo and colleagues from the Mayo Clinic, Rochester, USA, have reported that transfer of acute...

MRI selection slows down randomisation but therapy benefit similar to CTP

A subanalysis from the SWIFT PRIME trial has found that time to randomisation was significantly longer in magnetic resonance imaging (MRI)-selected patients in the...

Physiological time is brain

The DAWN trial results, presented at the European Stroke Organisation Conference (ESOC) by Tudor Jovin and Raul Nogueira, dramatically change the landscape for treatment...

DAWN of a new era: Time to save brain may be...

The much-anticipated results from the DAWN trial were finally revealed at the European Stroke Organisation Conference (ESOC; 16–18 May, Prague, Czech Republic) strongly indicating...

Good outcomes doubled with primary stroke centre protocol, study shows

A study published online by JAMA Neurology has found that when a specific primary stroke centre protocol was fully executed in the treatment of...

New process designed to streamline faster care for EMS triage, transport...

A new process, developed by the American Heart Association/ American Stroke Association, will help streamline the initial emergency care of stroke patients. The new Severity-based...

Patent issued to Perflow Medical for Stream Thrombectomy Net

Perflow Medical has announced the issuance of US Patent No. 9510855, by the US Patent and Trademark Office (USPTO), for the Stream Dynamic Neuro-Thrombectomy...

Enrolment stopped early in DAWN trial

An early end to patient enrolment in the DAWN trial has been activated following a pre-planned interim analysis of the data from the first...

ASTER RCT finds no significant difference between ADAPT and stent retriever...

The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique)...

Enrolment complete in ARISE II trial of EmboTrap device

Enrolment is now complete in the ARISE II clinical trial which is assessing the safety and effectiveness of the EmboTrap II revascularisation device (Neuravi),...

Wanted: More interventionalists

As the number of patients eligible for endovascular treatment of acute ischaemic stroke increases, centres across Europe must consider whether there are enough interventionalists...

First-in-human trial of Golden Retriever to take place at Karolinska

Amnis Therapeutics has received approval to perform a first-in-human clinical trial with its neuro thrombectomy device, the Golden Retriever. The approval was received from...

Endovascular therapy “appears to benefit” patients with large core and large...

Comparing the outcomes on computed tomography (CT) perfusion of patients with large baseline ischaemic cores undergoing endovascular therapy with the outcomes of matched controls...

SVIN announces “Stroke: Mission Thrombectomy 2020”

The Society of Vascular and Interventional Neurology (SVIN) has announced the launch of Mission Thrombectomy 2020, an initiative to enhance global efforts to improve...

Neuravi secures €15 million to fund expansion

Neuravi has announced €15 million in venture debt financing from IPF Partners, a leading alternative financing provider focused on the healthcare sector. This financing allows...

Stent retrievers more harmful to arterial wall than ADAPT in animal...

A new study comparing acute damage to the arterial wall caused by ADAPT (a direct aspiration first pass technique) or stent retrievers during thrombectomy...

New stent retriever introduces novel clot capture mechanism

Now that mechanical thrombectomy for the treatment of acute ischaemic stroke is on its way to becoming well-established practice, new devices are beginning to...

Increasing need for use of neuroprotective agents

While the proven success and corresponding uptake of mechanical thrombectomy for the treatment of acute ischaemic stroke has undoubtedly changed the face of stroke...

Expelling bottlenecks key to enhancing stroke pathways of care

There is no doubt now that mechanical thrombectomy has been established as the new standard of care for the treatment of emergent large vessel...

Earlier treatment with surgery to remove blood clot associated with less...

In an analysis that included nearly 1,300 patients with large-vessel ischaemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other...

ARTESp study of pREset device shows 62.5% positive clinical outcome after...

The treatment of mechanical thrombectomy represents a highly effective therapy in patients with acute ischaemic stroke. This was recently proven by four randomised controlled...

Neurointerventional community moves to “Get Ahead of Stroke”

In recent years the neurointerventional field has seen many changes, especially in the area of stroke treatment. It is now becoming increasingly important how...

US FDA broadens treatment indication for Stryker’s Trevo device

The US Food and Drug Administration (FDA) has allowed marketing of two Trevo (Stryker Neurovascular) clot retrieval devices as an initial therapy for ischaemic...

Randomised trial of Penumbra 3D revascularisation device meets primary endpoints

The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...

Penumbra launches ACE 68 reperfusion catheter in USA

Penumbra has launched its new ACE 68 reperfusion catheter in the USA.  The catheter is part of the Penumbra System, and was launched at...

Long-term experience confirms ADAPT as effective treatment for stroke

A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...

Debate: IV thrombolysis in acute stroke treatment is dead

It has now been universally accepted that mechincal thrombectomy for the treatment of patients with acute ischaemic stroke with large vessel occlusions is the...

World Stroke Organisation and Medtronic to promote stroke awareness

  The World Stroke Organization has announced a global partnership with Medtronic to increase stroke awareness through several initiatives. The two organisations will work together with...

ADAPT to the Challenges of Stroke

Acute ischaemic stroke is the second most common cause of death and disability in Europe. The evidence in the recently published or presented randomised...

Thousandth patient enrolled in Stryker’s Trevo Retriever Registry

Data from the first 500 patients enrolled in the Trevo Registry were presented at the European Stroke Organisation Conference (ESOC; 10-12 May, Barcelona, Spain)...

Golden Retriever safe and effective in pre-clinical trials

Amnis Therapeutics has announced successful results in its pre-clinical trials, which tested the safety and efficacy of the Golden Retriever neuro thrombectomy device. The...

Stent retriever technology named as a Top Medical Innovation by Cleveland...

Stent retriever technology has been named by the Cleveland Clinic as a top medical innovation. It was part of a list of the top...

“Push & Fluff” deployment proves better for radiopaque retriever

While the traditional unsheathing technique for the deployment of stent retrievers has proved successful in clinical use, in their experience, Raul Gomes Nogueira (Emory...

Medtronic acquires Lazarus Effect

Medtronic plc has announced that it has acquired Lazarus Effect, a Campbell, California, USA-based and privately-held medical device company focused on acute ischaemic stroke...

ACE64 study demonstrates high revascularisation rates, quick procedure times

Penumbra has announced that the results of the European multicentre study of the company’s ACE64 thrombectomy system were presented in the Abstract Presentations Session at...

FDA clears Penumbra ACE64 for acute ischaemic stroke patients

Penumbra has announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the US Food and Drug Administration for the revascularisation...

Study suggests feasibility of Baby Trevo for treatment of distal cerebrovascular...

Diogo Haussen and colleagues (Emory University School of Medicine, Atlanta, USA) report that their initial data suggest that treatment of distal cerebrovascular occlusions with...

Evidence builds for endovascular treatment of acute ischaemic stroke

With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.

Groundbreaking studies find that neurointerventional surgery reduces stroke mortality

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.

Stryker launches Trevo XP ProVue retrieval system

Stryker has launched the Trevo XP ProVue retrieval system, a second generation fully visible stent retriever to treat acute ischaemic stroke.